IMCIVREE (setmelanotide) injection

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Use in Patients with Bardet-Biedl Syndrome

Format

JPEG

Rhythm Pharmaceuticals, Inc.